Swiss National Bank Immunome Inc. Transaction History
Swiss National Bank
- $150 Billion
- Q3 2024
A detailed history of Swiss National Bank transactions in Immunome Inc. stock. As of the latest transaction made, Swiss National Bank holds 76,400 shares of IMNM stock, worth $725,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76,400
Previous 76,400
-0.0%
Holding current value
$725,800
Previous $924,000
20.78%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IMNM
# of Institutions
123Shares Held
47.1MCall Options Held
322KPut Options Held
1.91M-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.76MShares$54.7 Million0.05% of portfolio
-
Redmile Group, LLC San Francisco, CA4.89MShares$46.5 Million4.67% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$36.9 Million2.46% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$35.7 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.49MShares$33.1 Million0.03% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $115M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...